Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.70 +0.0% SILVER 68.63 +0.1% COPPER 6.71 +1.6% OIL 82.18 −3.3% PALLADIUM 1332.50 −2.3% HI 0.150 +0.0% DLTA 0.185 +0.0% EMO 0.395 −2.5% GR 0.070 +0.0% MGG 0.400 +2.6% EVI 0.540 −1.8% AVL 9.90 +23.6% VCG 1.53 +11.7% TTS 2.55 −1.9% SCMI 1.90 +2.7% RIO 3.60 +5.6% PUMA 0.145 +11.5% TRR 0.360 +0.0% TECT 2.68 +0.0% OGN 5.17 −2.1% GGD 4.41 +4.3% GOLD 4697.70 +0.0% SILVER 68.63 +0.1% COPPER 6.71 +1.6% OIL 82.18 −3.3% PALLADIUM 1332.50 −2.3% HI 0.150 +0.0% DLTA 0.185 +0.0% EMO 0.395 −2.5% GR 0.070 +0.0% MGG 0.400 +2.6% EVI 0.540 −1.8% AVL 9.90 +23.6% VCG 1.53 +11.7% TTS 2.55 −1.9% SCMI 1.90 +2.7% RIO 3.60 +5.6% PUMA 0.145 +11.5% TRR 0.360 +0.0% TECT 2.68 +0.0% OGN 5.17 −2.1% GGD 4.41 +4.3%
Production / Operations Routine +

Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership

Datametrex AI Limited Operational Expansion Masks Revenue Recognition Lag and Dilution Concerns

By The Northwire Desk — AI Analysis May 22, 2026 · 08:00 DM · 0.05 Datametrex AI Limited
Executive Summary
  • Imagine Health, a subsidiary or partner of Datametrex, has achieved Teaching Facility Status at its Calgary Capitol Hill clinic through a partnership with the University of Calgary Faculty.
  • Dr. Michael Tam (University faculty) was appointed to oversee medical residents, aiming to strengthen physician recruitment and retention across Edmonton and Vancouver networks.
  • Rheumatologist Dr. Richard Akintayo joined the Calgary clinic to address local wait times exceeding 18 months for routine appointments.
  • New physician Dr. Kennedy Uzodinma began walk-in and family medicine services at the Edmonton location effective June 1, 2026.
  • CEO Paul Haber stated this milestone deepens ties to the academic medical community and positions the company to attract physicians across its growing network.
Material Impact
  • The news confirms operational expansion in the healthcare vertical but lacks quantified financial metrics (revenue or profit contribution).
  • Compared to the April 2026 $6M data centre contract, this update is incremental regarding immediate cash flow visibility.
  • The stock price has declined significantly from November 2025 highs ($0.13) to current levels ($0.05), suggesting market skepticism despite positive operational news.
  • This announcement validates the healthcare strategy but does not materially alter the valuation model without disclosed revenue figures for Imagine Health.
  • Given the lack of financial specifics, the impact is classified as Routine - Positive rather than Material.
DM · Price
Company Overview
  • Datametrex AI Limited operates across three main verticals: Data Centre Infrastructure (Nutanix HCI), Intellectual Property Monetization (Paymetrex), and Healthcare Services (Imagine Health).
  • Flagship Project 1: Nutanix-based hyperconverged infrastructure (HCI) solutions deployed in South Korea and expanding to North America.
  • Flagship Project 2: Paymetrex patent licensing program monetizing mobile payments IP, including SoftPOS technologies.
  • Flagship Project 3: Imagine Health clinic network providing medical services with AI-integrated Electronic Medical Records (EMR).
  • The company utilizes a "land and expand" strategy across these sectors to build recurring revenue streams.
Read the original news release →

More from Datametrex AI Limited

Jun 30, 2026 · 08:00

Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative

M&A / Property Jun 15, 2026 · 08:30

Small-cap tech pivot: $650k software contracts and patent licensing progress offset by persistent losses and a 70% stock drawdown.

Other Jun 03, 2026 · 08:00

Datametrex AI Secures $1.8M in Nutanix Contracts as Margin Compression and Cash Burn Weigh on Venture Stock

Other Jun 01, 2026 · 08:00

Datametrex AI Advances Patent Monetization with Hilco Global, but Execution Risks and Dilution Weigh on Shareholder Value

Other Apr 24, 2026 · 08:00

Datametrex pivots to quantum encryption amid revenue stagnation and share dilution

Other Apr 09, 2026 · 07:30

“$6 M Five‑Year Contract Adds Predictable Recurring Revenue, Boosts Datametrex Outlook”

Other